RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

September 6, 2018

Study Completion Date

September 6, 2018

Conditions
Opioid-Related DisordersOpioid-use DisorderDrug AddictionSubstance Use Disorders
Interventions
OTHER

self-administered, e-health application

"RETAIN is a self-administered, e-health application and includes short videos in which patients who are successfully engaged in MAT discuss what they wish they had known about MAT and its benefits when they started treatment. The intervention is designed to maximize scalability - the administration would entail handing an electronic device (e.g., tablet, laptop, etc.) to an individual who would then self-administer the intervention."

Trial Locations (1)

45229

University of Cincinnati Addiction Sciences Division, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT03411265 - RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing | Biotech Hunter | Biotech Hunter